Contraceptive Technology Update – May 1, 2011
May 1, 2011
View Issues
-
Female condoms hit the spotlight — Will U.S. women see more options?
Since its introduction in 2009, use of the non-latex FC2 Female Condom (Women's Health Co., Chicago) has grown. -
Do more pill packs mean fewer pregnancies?
What is your facility's policy on providing multiple pill packs? Results of a new study might make you rethink your strategy. -
New patch options — Could they catch on?
When the Ortho Evra transdermal contraceptive (Ortho Women's Health & Urology, Raritan, NJ) was introduced in 2002, use of the patch caught on quickly with young women. -
Low-literacy material targets correct OC use
You have just reviewed instructions on proper oral contraceptive (OC) use with your patient, a 22-year-old mother of three. -
Antidepressant eyed to reduce hot flashes
[Editor's note: This story discusses off-label use of the antidepressant medication escitalopram (Lexapro, Forest Laboratories, New York City).] -
Research eyes chlamydia, ectopic pregnancy link
A ruptured ectopic pregnancy is the leading cause of maternal mortality in the first trimester and accounts for 10 to 15% of all maternal deaths. -
OB/GYN Quarterly Update: Intrauterine devices are on the move — Your most pressing questions addressed
A 25-year-old G3P1021 presents to clinic concerned that her intrauterine device (IUD) strings feel longer. She is otherwise asymptomatic. -
OB/GYN Quarterly Update: Heavy menstrual bleeds given new treatment
After two pretreatment cycles, 196 patients with menorrhagia were randomized to tranexamic acid or placebo. -
OB/GYN Quarterly Update: Heavy menstrual bleeds given new treatment
Recent investigation into the molecular pathogenesis of epithelial ovarian cancer has implicated two dominant phenotypes.